290 related articles for article (PubMed ID: 24239508)
1. Reciprocal role of vitamin D receptor on β-catenin regulated keratinocyte proliferation and differentiation.
Hu L; Bikle DD; Oda Y
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():237-41. PubMed ID: 24239508
[TBL] [Abstract][Full Text] [Related]
2. 1α,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway.
Jiang YJ; Teichert AE; Fong F; Oda Y; Bikle DD
J Steroid Biochem Mol Biol; 2013 Jul; 136():229-32. PubMed ID: 23026511
[TBL] [Abstract][Full Text] [Related]
3. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes.
Sølvsten H; Svendsen ML; Fogh K; Kragballe K
Arch Dermatol Res; 1997 May; 289(6):367-72. PubMed ID: 9209684
[TBL] [Abstract][Full Text] [Related]
5. 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes.
Janjetovic Z; Tuckey RC; Nguyen MN; Thorpe EM; Slominski AT
J Cell Physiol; 2010 Apr; 223(1):36-48. PubMed ID: 20020487
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of epidermal function by VDR coactivators.
Bikle DD; Teichert A; Arnold LA; Uchida Y; Elias PM; Oda Y
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):308-13. PubMed ID: 20298785
[TBL] [Abstract][Full Text] [Related]
7. Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer.
Bikle DD; Oda Y; Tu CL; Jiang Y
J Steroid Biochem Mol Biol; 2015 Apr; 148():47-51. PubMed ID: 25445917
[TBL] [Abstract][Full Text] [Related]
8. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
9. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
Imai Y; Pike JW; Koeffler HP
Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
11. Hairless suppresses vitamin D receptor transactivation in human keratinocytes.
Xie Z; Chang S; Oda Y; Bikle DD
Endocrinology; 2006 Jan; 147(1):314-23. PubMed ID: 16269453
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk of Aryl Hydrocarbon Receptor (AHR)- and Vitamin D Receptor (VDR)-signaling in Human Keratinocytes.
Christofi C; Lamnis L; Stark A; Palm H; Römer K; Vogt T; Reichrath J
Anticancer Res; 2022 Oct; 42(10):5049-5067. PubMed ID: 36191995
[TBL] [Abstract][Full Text] [Related]
13. The effect of 1,25 dihydroxyvitamin D3 treatment on the mRNA levels of β catenin target genes in mice with colonic inactivation of both APC alleles.
DeWitt M; Johnson RL; Snyder P; Fleet JC
J Steroid Biochem Mol Biol; 2015 Apr; 148():103-10. PubMed ID: 25597951
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
15. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.
Zbytek B; Janjetovic Z; Tuckey RC; Zmijewski MA; Sweatman TW; Jones E; Nguyen MN; Slominski AT
J Invest Dermatol; 2008 Sep; 128(9):2271-80. PubMed ID: 18368131
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
Jensen TJ; Henriksen LO; Sølvsten H; Kragballe K
Biochem Pharmacol; 1998 Mar; 55(6):767-73. PubMed ID: 9586948
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice.
Sakai Y; Demay MB
Endocrinology; 2000 Jun; 141(6):2043-9. PubMed ID: 10830288
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
19. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors.
Sørensen S; Sølvsten H; Politi Y; Kragballe K
Skin Pharmacol; 1997; 10(3):144-52. PubMed ID: 9287395
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D signaling regulates oral keratinocyte proliferation in vitro and in vivo.
Yuan FN; Valiyaparambil J; Woods MC; Tran H; Pant R; Adams JS; Mallya SM
Int J Oncol; 2014 May; 44(5):1625-33. PubMed ID: 24626468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
